Latest Shareholder Approvals News

Caspin Resources has completed its acquisition of the Bygoo Tin Project in NSW and is set to begin a significant drilling campaign, backed by a recent $1.6 million capital raise.

Entyr Limited has launched a $9.5 million capital raising via a Share Purchase Plan and Placement Offer, aiming to recapitalize and return to ASX trading following its recent voluntary administration.

Merchant House International Limited reports the completion of its Tianjin asset sale and the cessation of AMI operations, signaling a strategic wind-up and delisting plan.

Noble Helium has selected three initial drill sites in its North Rukwa Project in Tanzania, backed by significant helium detections and a flexible funding package including convertible notes and an equity facility. However, drilling has been deferred due to seasonal rains.

Amcor plc has taken a pivotal step in its proposed merger with Berry Global by filing the definitive joint proxy statement with the SEC, setting the stage for shareholder votes in February. Integration planning is well underway as both companies prepare to unite their packaging expertise.

Adisyn Ltd has successfully raised $10 million through a heavily oversubscribed placement, signaling strong institutional confidence in its graphene-enhanced semiconductor technology. The capital will accelerate development, commercial partnerships, and operational scaling.

Poseidon Nickel has taken a strategic leap with a proposed merger with Horizon Minerals, aiming to combine resources and processing infrastructure. Concurrently, exploration programs at Black Swan and Lake Johnston have unveiled significant gold and lithium anomalies, underscoring the potential of the combined entity.

Amcor plc and Berry Global Group, Inc. have entered into a definitive all-stock merger agreement, positioning the combined entity as a global leader in consumer and healthcare packaging with expected annual synergies of $650 million.

DevEx Resources reports significant progress in its uranium exploration projects at Nabarlek and Murphy West, with new tenement applications nearing grant and ongoing evaluation of high-grade drilling results.

Brazilian Critical Minerals Limited reported a net cash outflow from operating activities in the December 2024 quarter but maintains a solid cash position supported by significant unused financing facilities.

InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.

Javelin Minerals has completed Phase 1 drilling at its Coogee Gold Project with assay results pending, while finalizing the acquisition of the Eureka Gold Project and preparing for further drilling in early 2025.